PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Augmedix, Inc. (AUGX)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISINUS05105P1075
CUSIP05105P107
SectorHealthcare
IndustryHealth Information Services

Highlights

Market Cap$192.28M
EPS-$0.50
Revenue (TTM)$44.86M
Gross Profit (TTM)$13.95M
EBITDA (TTM)-$17.68M
Year Range$1.50 - $6.25
Target Price$6.48
Short %2.62%
Short Ratio1.81

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds to compare with AUGX

Augmedix, Inc.

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Augmedix, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-40.00%-20.00%0.00%20.00%40.00%OctoberNovemberDecember2024FebruaryMarch
-19.20%
32.11%
AUGX (Augmedix, Inc.)
Benchmark (^GSPC)

S&P 500

Returns By Period

Augmedix, Inc. had a return of -30.94% year-to-date (YTD) and 139.05% in the last 12 months.


PeriodReturnBenchmark
Year-To-Date-30.94%10.04%
1 month-7.55%3.53%
6 months-14.95%22.79%
1 year139.05%32.16%
5 years (annualized)N/A13.15%
10 years (annualized)N/A10.96%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2024-24.44%-0.45%
202318.02%7.74%-14.56%20.00%10.80%

Risk-Adjusted Performance

Risk-Adjusted Performance Indicators

This table presents risk-adjusted performance metrics for Augmedix, Inc. (AUGX) and compares them with a selected benchmark (^GSPC). These performance indicators assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratioSortino ratioOmega ratioCalmar ratioUlcer Index
AUGX
Augmedix, Inc.
1.16
^GSPC
S&P 500
2.76

Sharpe Ratio

The current Augmedix, Inc. Sharpe ratio is 1.16. A Sharpe ratio greater than 1.0 is considered acceptable.


Rolling 12-month Sharpe Ratio0.001.002.003.004.00OctoberNovemberDecember2024FebruaryMarch
1.16
2.76
AUGX (Augmedix, Inc.)
Benchmark (^GSPC)

Dividends

Dividend History


Augmedix, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-60.00%-50.00%-40.00%-30.00%-20.00%-10.00%0.00%OctoberNovemberDecember2024FebruaryMarch
-46.13%
0
AUGX (Augmedix, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Augmedix, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Augmedix, Inc. was 85.60%, occurring on Dec 19, 2022. The portfolio has not yet recovered.

The current Augmedix, Inc. drawdown is 46.13%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-85.6%Apr 8, 2021430Dec 19, 2022

Volatility

Volatility Chart

The current Augmedix, Inc. volatility is 25.07%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%5.00%10.00%15.00%20.00%25.00%30.00%35.00%OctoberNovemberDecember2024FebruaryMarch
25.07%
2.82%
AUGX (Augmedix, Inc.)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Augmedix, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Income Statement


Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly

TTM
Revenue

Total Revenue

0.00

Cost Of Revenue

0.00

Gross Profit

0.00
Operating Expenses

Selling, General & Admin Expenses

0.00

R&D Expenses

0.00

Total Operating Expenses

0.00
Income

Income Before Tax

0.00

Operating Income

0.00

EBIT

0.00

Earnings From Continuing Operations

0.00

Net Income

0.00

Income Tax Expense

0.00

Interest Expense

0.00

Other Non-Operating Income (Expenses)

0.00

Extraordinary Items

0.00

Discontinued Operations

0.00

Effect Of Accounting Charges

0.00

Non Recurring

0.00

Minority Interest

0.00

Other Items

0.00
Values in undefined except per share items